Figure 1

Imaging modalities delivery of RNAi therapeutics in cancer therapy and clinical applications

Loutfy H Madkour*

Published: 04 March, 2021 | Volume 5 - Issue 1 | Pages: 005-034

(A) Intensity size distribution of HAI-NGs determined by DLS. (B) TEM image of HAI-NGs (scale bar: 100 nm). (C) Fluorescent spectrum of HAI-NGs before and after crosslinking by UV irradiation. The insert shows a photograph of HAI-NGs under UV light. (D) Triggered destabilization of HAI-NGs in 10 mM GSH.

" alt="jro-aid1035-g011"class="img-responsive img-rounded " style="cursor:pointer">

Figure 1:

(A) Intensity size distribution of HAI-NGs determined by DLS. (B) TEM image of HAI-NGs (scale bar: 100 nm). (C) Fluorescent spectrum of HAI-NGs before and after crosslinking by UV irradiation. The insert shows a photograph of HAI-NGs under UV light. (D) Triggered destabilization of HAI-NGs in 10 mM GSH.

Read Full Article HTML DOI: 10.29328/journal.jro.1001035 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?